Voyager Therapeutics, Inc.VYGRNASDAQ
Loading
Gross Profit Over TimeContracting
Percentile Rank75
5Y CAGR-8.3%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

5Y CAGR
-8.3%/yr
Long-term compound
Percentile
P75
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$40.37M-49.5%
2024$80.00M-49.3%
2023$157.84M+1162.4%
2022$-14.86M+59.2%
2021$-36.37M-158.3%
2020$62.38M+506.5%
2019$-15.34M+73.2%
2018$-57.29M-9.9%
2017$-52.13M-86.0%
2016$-28.03M-